These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8489292)

  • 21. [The study of 5-FU levels and pyrimidine nucleoside phosphorylase (PyNPase) activity in human breast cancer tissue after administration of 5'-deoxy-5-fluorouridine (5'-DFUR)].
    Yayoi E; Takatsuka Y; Miyauchi K; Hirai T; Aikawa T; Maeura Y; Kaji M; Kitada M; Kotsuma Y; Satomi T
    Gan To Kagaku Ryoho; 1990 Jul; 17(7):1371-4. PubMed ID: 2142401
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effects of alternating chemotherapy with 2 non-cross-resistant drug combinations on human alimentary and breast cancer xenografts in nude mice].
    Fujita F; Fujita M; Yamauchi T; Sakamoto Y; Shimozuma K; Inaba H; Taguchi T
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1297-304. PubMed ID: 2953311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic and pharmacodynamic comparison of fluoropyrimidine derivatives, capecitabine and 5'-deoxy-5-fluorouridine (5'-DFUR).
    Ebi H; Sigeoka Y; Saeki T; Kawada K; Igarashi T; Usubuchi N; Ueda R; Sasaki Y; Minami H
    Cancer Chemother Pharmacol; 2005 Aug; 56(2):205-11. PubMed ID: 15844007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy of long-term oral chemotherapy with 5'-deoxy-5-fluorouridine and cyclophosphamide for recurrent breast cancer.
    Iba T; Kidokoro A; Fukunaga M; Sugiyama K; Aihara N; Suda M
    Int J Clin Oncol; 2004 Oct; 9(5):383-7. PubMed ID: 15549589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Influence of intratumor administration of OK-432 on the tumor selectivity of 5'-DFUR].
    Ogawa K; Katsube T; Konno S; Miura K; Wakasugi S; Watanabe T; Shimakawa T; Ishikawa S; Naritaka Y; Yagawa H
    Gan To Kagaku Ryoho; 1995 Dec; 22(14):2095-100. PubMed ID: 8607621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The efficacy of combination chemotherapy of 5'-deoxy-5-fluorouridine (5'-DFUR), cyclophosphamide (CPA) and medroxyprogesterone acetate (MPA) for bone metastasis in breast cancer patients].
    Iba T; Kidokoro A; Fukunaga M; Sugiyama K; Aihara N; Suda M
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):973-7. PubMed ID: 11478147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative effects of the administration period of adjuvant chemotherapy using doxifluridine (5'-DFUR) for 1 year versus 3 years after breast cancer surgery by the Shimane Breast Cancer Study Group.
    Shimane Breast Cancer Study Group
    Anticancer Res; 2006; 26(1B):591-7. PubMed ID: 16739326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical effect of 5'-deoxy-5-fluorouridine (5'-DFUR)].
    Nakano Y; Ohota J; Fujita M; Taguchi T
    Gan No Rinsho; 1985 May; 31(6 Suppl):746-50. PubMed ID: 3162050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Randomized comparison of continuous and intermittent oral administration of 5'-deoxy-5-fluorouridine in the treatment of advanced gastric cancer; a phase II trial by the Multi-institutional Cooperative Study Group].
    Niitani H; Kurihara M; Hasegawa K; Hatta Y; Suwa T; Tsuboi E; Yasui A; Yoshimori K; Kawachi M; Taguchi S
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3345-50. PubMed ID: 2961307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Phase II study of 5'-DFUR (5'-deoxy-5-fluorouridine) by the Cooperative Study Group].
    Taguchi T; Sakai K; Terasawa T; Irie K; Okajima K; Yamamoto M; Kawahara T; Satomi T; Tomita K; Yamaguchi A
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2179-84. PubMed ID: 2933001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical usefulness of oral combination chemotherapy of 5'-deoxy-5-fluorouridine (5'-DFUR) and cyclophosphamide for metastatic breast cancer.
    Yamashita T; Yamashita H; Itoh Y; Karamatsu S; Itoh K; Hara Y; Ando Y; Sugiura H; Kuzushima T; Toyama T; Iwata H; Kobayashi S; Iwase H
    Breast Cancer; 2006; 13(4):334-9. PubMed ID: 17146158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Phase II study of 5'-deoxy-5-fluorouridine (5'-DFUR) in patients with malignant cancer--a multi-institutional cooperative study].
    Niitani H; Kimura K; Saito T; Nakao I; Abe O; Urushizaki I; Ohta K; Yoshida Y; Kimura T; Kurihara M
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):2044-51. PubMed ID: 2932059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A 5'-DFUR + CPA + THP therapy that was effective for paclitaxel-refractory pulmonary metastasis of breast cancer--a case report].
    Kitahara S; Ogata H; Katagiri T; Nonaka K; Shiba T
    Gan To Kagaku Ryoho; 2002 Jan; 29(1):111-4. PubMed ID: 11816465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case of inflammatory breast cancer successfully treated with 5'-DFUR and MPA].
    Kusama M; Koyanagi Y; Sekine M; Serizawa H; Ebihara Y; Hirota T; Nakamura Y; Matsunaga T
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):2049-52. PubMed ID: 8085857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Co-operative clinical evaluation of 5'-DFUR tablets for breast cancer at 31 institutions].
    Morimoto K; Taguchi T; Ohta J; Miura S; Ueda N; Yayoi K; Inaji H
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):1041-8. PubMed ID: 1385688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of 5'-deoxy-5-fluorouridine on human gastrointestinal and breast cancers xenografted to nude mice].
    Fujita F; Fujita M; Taguchi T
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1635-43. PubMed ID: 6236751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ZD1839 (Iressa) modifies the activity of key enzymes linked to fluoropyrimidine activity: rational basis for a new combination therapy with capecitabine.
    Magné N; Fischel JL; Dubreuil A; Formento P; Ciccolini J; Formento JL; Tiffon C; Renée N; Marchetti S; Etienne MC; Milano G
    Clin Cancer Res; 2003 Oct; 9(13):4735-42. PubMed ID: 14581344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Investigation of 5-fluorouracil (5-FU) levels and pyrimidine nucleoside phosphorylase activities in the tissues from patients with uterine cervical and ovarian cancers after oral administration of 5'-DFUR].
    Noda K; Watanabe Y; Ikeda M; Takeuchi K; Hasegawa K; Kinugasa M; Sekiba K; Kobashi Y; Ohiwa T; Odagiri H
    Gan To Kagaku Ryoho; 1991 Dec; 18(15):2551-5. PubMed ID: 1836128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical phase II study of 5'-DFUR for cancer of the digestive organs by a cooperative study group].
    Urushizaki I; Kogo Y; Kouda K; Ishitani K; Niitsu Y; Matsuda M; Gocho Y; Koyama R; Nagai T; Saijo N
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2358-64. PubMed ID: 3000300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A comparative study of 5'-DFUR and tegafur in recurrent breast cancer].
    Taguchi T; Terasawa T; Abe O; Yoshida Y; Tominaga T; Ogawa N
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):2052-60. PubMed ID: 2932060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.